Data showing that domestic investors were net sellers yesterday proved to be a dampener.
The market, according to traders, is in a phase of consolidation after scaling record highs following BJP's mammoth win in UP and Uttarakhand and formation of its governments in Goa and Manipur.
After hitting the day's high of 29,585.05, the 30-share Sensex closed at 29,485.45, down 33.29 points, or 0.11 per cent. The gauge had fallen 130.25 points in the previous session.
"While FDA observations kept pharma space depressed, banking stocks were also under pressure from potential farm loan waivers," said Anand James, Chief Market Strategist, Geojit Financial Services.
But the rupee's rising clout against the dollar on robust capital inflows restricted the losses.
Divi's Laboratories today slumped 19.77 per cent to a 52-week low of Rs 634.35 after the company said the US health regulator has issued an import alert on the products manufactured at one of its units in Visakhapatnam.
Idea Cellular tumbled 4.76 per cent, falling for the second session in a row, after announcement of its merger with Vodafone India to create the country's largest mobile phone operator.
Healthcare dropped 1.44 per cent followed by bank, auto, PSU and oil and gas. However, realty rose by 1.35 per cent and FMCG 1.01 per cent.
While foreign portfolio investors (FPIs) bought shares worth a net Rs 56.67 crore yesterday, domestic institutional investors (DIIs) sold shares worth a net Rs 536.21 crore, as per provisional data.
Drug major Dr Reddy's topped the loser's list by slumping 4.36 per cent while Axis Bank shed 3.28 per cent. Other major losers were GAIL, Maruti Suzuki, RIL, Sun Pharma and ICICI Bank.
Major Asian indices ended on a mixed note. Europe displayed a similar trend.
In the domestic market, 17 scrips out of the 30-share
Sensex pack ended lower while 13 rose.
The market breadth remained negative as 1,692 stocks ended lower 1,089 higher while 193 ruled steady.
The total turnover fell to Rs 5,206.02 crore, from Rs 56,820.64 crore yesterday.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
